Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Critically, there is no rigorous, comparative research to definitively prove the methods are equally effective or interchangeable
Last reviewed: June 10, 2026 Last updated: June 10, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
However, they appear to produce similar results to injectables
Even comparing Retatrutides Phase 2 results against Wegovys best available data, the gap is substantial
US$ 25.83
US$ 29.32
US$ 25.43
US$ 22.78
US$ 28.50
US$ 23.95
US$ 23.19
US$ 21.11
US$ 29.43
